CVA Family Office’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.51K Buy
32
+2
+7% +$285 ﹤0.01% 1360
2025
Q4
$4.99K Buy
30
+13
+76% +$2.17K ﹤0.01% 887
2025
Q3
$3.33K Buy
17
+3
+21% +$493 ﹤0.01% 941
2025
Q2
$1.27K Sell
14
-16
-53% -$1.26K ﹤0.01% 1051
2025
Q1
$1.79K Buy
+30
New +$2.77K ﹤0.01% 1025

Other funds holding ALAB

CVA Family Office's ALAB Position: Q1 2026 in Review

CVA Family Office increased its Astera Labs (ALAB) stake by 6.7% in Q1 2026, buying an estimated $285 and bringing the position to 32 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1360.

CVA Family Office first reported a position in ALAB in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.99K in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • CVA Family Office held 32 shares of Astera Labs worth $3.51K as of Q1 2026.
  • CVA Family Office bought 2 Astera Labs shares in Q1 2026, an estimated $285.
  • Astera Labs made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1360 holding.
  • CVA Family Office first reported a position in Astera Labs in Q1 2025 and has held it in 5 quarters since.
  • CVA Family Office's Astera Labs position peaked at $4.99K in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.